Member Info for VikR

Definitely agree with sentiment

Nothing can happen for days/weeks and months and then all of a sudden we get a unilateral upsurging re rate. This is the most likely trajectory for Rock, always best to accumulate at the supposedly quiet times at the bottom end of the Lassonde curve

Makes nil commercial acumen to sell at this level now. Anyone with spare funds should follow the money. Multiple director buys tells us more then any speculation ever can. This is only going one way and the re rate will be substantive, probably one of the biggest on the stock market when it does occur

Everything this company is doing is amazing and the way they are diversifying and not standing still waiting for the lead addiction workflows to conclude is testament to the proactivity of the entire BOD. Every single newsflow going forward will be a catalyst but the absolute biggest catalyst will be the phase 2b permission by FDA following WuXis bridging work completion. As spravato is already licensed, flying through the rest of the clinical trials will be a breeze for repurposed esketamine.

‘During Q4 2025, preparatory work continued with WuXi AppTec on a pharmacokinetic bridging programme to support regulatory alignment. Initial data are expected in Q1 2026, with further progress through Q2 2026’

When WuXI complete there work and SVNS RNS it, thats going to be a good day for the SP. With Professor Nutts stamp of approval and a well compiled case FDA approval will be a given.

Load and hold these valuable shares for 2026/27/28. One of the best long term holds in the market

Had way too many funds tied up in here to see this crash sub 5p so hopefully we have put an end to that. Glad to be back and loaded up to pre 2025 Autumn levels and can now patiently hold for the newsflow to unfold whether that be in a week / month or many months. If some of my other metal exploration plays make some returns will use that as an opportunity to continually load here now. Seeing the big buys last few days certainly seems bigger funded investors share a similar view.

Good luck everyone and here’s hoping for a step closer to p140 on its journey to success.

Everyman and there dog seem to be promoting this on social media and it seems to be a hot pick of many professional astute full time investors. I have shared my passion and enthusiasm on some of the posts as nice to know everyone has high hopes for GSCU this year. I am quite eager for this to cross the 10p psychological barrier at some point this year so we can let this go on a real unilateral upward run thereafter.

In Sam Garrett I have full faith to make this massive

Multi million district scale gold opportunity. BCM are not chucking money for exploration without doing extreme due diligence.

This is a mammoth opportunity in the making and a steal at the current SP. Very tempted to go the whole hog and chuck 6 figures + in here.

Building a multi-million-ounce district. Looking forward, if drilling does indeed support generation of

an MRE for MB01-N and the top end of the ET is achieved, this would translate to a 1.5Moz combined

resource for the Mbe prospects. Additionally, there are other geochemical targets on the wider Mbe

licence that have seen little in the way of exploration, let alone the multiple kilometre-scale gold-in-

soil anomalies that have been identified on the other four contiguous licences within the 2,266km2

Eastern CLP area. Consequently, through systematic exploration it’s not difficult to visualise a pathway

to a considerably larger resource inventory for Oriole.

We don’t believe that the company’s current market value (£15m) reflects this exciting growth opportunity set against the backdrop of favourable gold price tailwinds and a reinvigorated industry quest for shallow gold deposits with development potential. Cameroon remains a new frontier for gold exploration but herein lies the opportunity. This is an excellent start for Oriole at MB01-N with the results from the first two holes reinforcing the prospectivity of the Mbe licence and the potential to add further gold ounces, foreshadowing what we believe will be a pivotal year for the company.

My 15k buy showing as an unknown trade at 11:57

onwards and upwards (insert rocket here)

I have taken advantage of the dip today and purchased 4883566 @ 0.307 for 15k just now

Any dips here pre 0.40 are a blessing and I am going to continue building a big stake.

Brilliant play for 2026

Managed to finally get a chunk at £5k for 0.38p 13005338 shares in one go just now

Loading and holding here in increments

They have an annual subscription to this event and have been attending for many years and will continue to do so irrespective of p140. There are also other drugs within their portfolio to be promoted.

More publicity with a patent pending product is never a bad thing and can only add as an adjunct.

Can’t knock the effort and enthusiasm of current CEO.

Excellent risk to reward at this SP

‘And so it begins - 2026 - a transformational year for VALIRX PLC. Looking forward to JPM as the schedule fills up. Those who know it will know it’s a brutal meeting but a great opportunity to pitch our SPVs.

Particularly excited about our 3k repurposing program given it can deliver “closer to clinic” assets in a faster, ethical approach which really leverages Inaphaea BioLabs’s New Approach Methadologies including our patient derived cell Models and our Digital Twin partnership with TwinEdge Bioscience.

We’ll also be pitching Val201 2.0 as work on the new formulation begins this month as we expect to receive the first new format peptides.

Finally things another great opportunity to showcase Cytolytix and have meetings lined up with our partner Omios Biologics so looking forward to catching up with Aldo Pourchet.

We’ll be at the partnering meetings (search a ValiRx on the partneringOne platform) and also can meet outside the Biotech showcase for anyone circling the event simple feel free to ping me directly.’

Had about 15k to top up but it would not let me, can only buy in small amounts of £500 to £1k at a time. Given the recent director buys @ 0.4p no brainer to top up at these levels. Will have to make do with the few k top up and try again in the future

Now we have got over 2025 now seems a good time as any for a re entry so on that note I have made some top ups again as I believe sentiment will start returning to get the SP momentum back up and hopefully a fundamental RNS drop of deal conclusion does the remainder of the exponential uplift. Looking forward to seeing which pharma partner has decided to take on p140 in its diagnostic and treatment format and given the time limited patent years it makes little sense to keep on delaying a finale conclusion for the companies involved. The facts still remains that p140 is a unique first in class drug and whatever has happened or will happen going forward groundbreaking science has been achieved here by all the great scientists involved.

Big things on the horizon fully loaded here and selling nothing until a substantive re rate. Hoping this and JAN give me the best gold buys of 2026 while my other diversified investments do there thing.

LOAD AND STRONG HOLD

After a massive eventful year in 2025 this has now paved the way for a baseline to the upside. I neutralised my profits by buying higher up on the last run end of Q4 2025 but it bothers me not as I hold out for the long term. As and when I am ready to make some more sizeable buys I will keep you all updated. In the interim make no mistake when Dr Kinkaid drops the conclusion of the NCI sign off it will be a huge stepping stone. The tech is too good for NCI to walk away and the good thing there is no one else for them to approach

Stay resolute, ignore the noise and watch the re rate unfold over the coming period.

With the assets in situ across a diverse portfolio, 2026 is going to be the year of delivery

Having had an opportunity to speak to AT this year and have a follow up with comprehensive emails it is reassuring to see an ethical, transparent and honest CEO leading the helm with no added hype. We are one RNS away from a significant re rate and thereafter should see successive news happening more frequently. I have locked a few million shares in my little ones ISA account which cant be withdrawn for the next 6 years, I plan to keep on adding into it each fiscal year and keep as many shares away from the hands of the MMs.

It is apparent the market did not like the news of no news flow until Q1-Q4 2026 but at least AT was honest and not giving false hope. It wont drop back anymore now so A MASSIVE GOOD BUY at these levels for those on the sidelines.

The next RNS to land has got to set the foundation for TRP and be the first in a long line of successive step wise re rates. A lot of patience has been exercised here over the last 14 months and only made additions along the way with no sells. Extremely close now to contemplate selling any so holding very near and dear and anticipating the exciting news drop. Hope it sends the market absolutely crazy and a buying frenzy ensues, the clock ticks closer to success.

Wholeheartedly agree with this sentiment,

as a scientist myself it is clear as day to see that Aptamer group is in the right industry at the right time to exploit maximum throughput of its technology. The contracts will continue growing and this is without the big announcements regarding its own proprietary projects - RE unilever deodorant and the multibillion liver fibrosis aptamers. These are supernumerary to the inbound contracts which seem to be flying in from all angles.

Big re rate due in 2026, getting in around these levels is a big blessing

I have heard Charles Archer discussing this stock when it was well below sub 1p. His enthusiasm was as equally high for it back then and it seems he has called it completely correct as to go from 0.6p to touch 4p within the year is some surge. It looks like when this decides to upsurge again it will rally extremely hard. The products being developed will be of high calibre and command premium money considering the collaborators involved.

2026 will be huge for ALRT pit stop number one - - - 10p

Morning LTHs

did some research on the backstory, looks compelling and a very good time to be in with silver in demand and price action looking to continually surge upwards with some predicting a very ambitious 200 $ an ounce at some point in the future.

got 5580683 shares for £8k this morning

hope the story continues to unfold successfully